Prevalence
Causes
Clinical
features
Investigations
Therapy
Prognosis
|  |  | | Investigations |
Take the following tests before giving a blood transfusion:
Macrocytic anaemia
-
serum folate
d
-
serum B
12
(cobalamin)
b
-
urine methylmalonic acid (MMA)
b
or serum MMA
b
Why?
A normal serum cobalamin makes cobalamin
deficiency unlikely.
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
anaemia macrocytosis, dementia or neuropathy
b
(pre-test probability: 1.2%)
|
cobalamin deficiency
(Schilling test)
|
serum B
12
(cobalamin)< 133 pmol/l
|
2.2
(1.8 to
2.6)
|
2% |
0.00
(0.00 to
0.33)
|
0% |
A raised urinary or serum MMA makes cobalamin
deficiency likely.
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
anaemia macrocytosis, dementia or neuropathy
b
(pre-test probability: 1.2%)
|
cobalamin deficiency
(
Schilling test
)
|
urinary MMA > 5 µg/ mg creatinine
|
47
(12 to
190)
|
32% |
0.19
(0.070 to
0.53)
|
0.2% |
suspected cobalamin deficiency
b

(pre-test probability: 74%)
|
cobalamin deficiency
(
Schilling test, bone marrow
)
|
serum MMA > 0.34 µmol/
|
11
(1.6 to
69)
|
97% |
0.036
(0.0051 to
0.25)
|
9% |
|